Zobrazeno 1 - 10
of 288
pro vyhledávání: '"Elisabeth Meier"'
Autor:
Lefkowitz, Mary
Publikováno v:
The Catholic Biblical Quarterly, 2007 Jul 01. 69(3), 593-594.
Externí odkaz:
https://www.jstor.org/stable/43726083
Autor:
Morrow, William
Publikováno v:
The Catholic Biblical Quarterly, 2006 Jul 01. 68(3), 529-531.
Externí odkaz:
https://www.jstor.org/stable/43727602
Autor:
Gnuse, Robert1 rkgnuse@Loyno.edu
Publikováno v:
Human Rights Review. Dec2008, Vol. 9 Issue 4, p549-551. 3p.
Autor:
Robert Gnuse
Publikováno v:
Human Rights Review. 9:549-551
Autor:
Selvidge, Marla J.
Publikováno v:
The Catholic Biblical Quarterly, 1986 Apr 01. 48(2), 348-349.
Externí odkaz:
https://www.jstor.org/stable/43717211
Autor:
Gaventa, Beverly Roberts
Publikováno v:
The Catholic Biblical Quarterly, 1984 Oct 01. 46(4), 802-803.
Externí odkaz:
https://www.jstor.org/stable/43716845
Autor:
Jeremy Corley
Publikováno v:
The Heythrop Journal. 48:632-633
Autor:
Susanne Rogers, Brigitte Eberle, Deborah R. Vogt, Elisabeth Meier, Lorenz Moser, Silvia Gomez Ordoñez, Susanne Desborough, Oliver Riesterer, Istvan Takacs, Paul Hasler, Stephan Bodis
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Background: The objective benefits of low dose radiotherapy (LDRT) for non-malignant joint disorders are controversial. This study evaluated changes in pain, quality of life (QoL) and function after LDRT for epicondylitis, plantar fasciitis, and fing
Externí odkaz:
https://doaj.org/article/0dea27e0ad3243f9b2dedad83691ee13
Autor:
Corley, Jeremy1 (AUTHOR)
Publikováno v:
Heythrop Journal. Jul2007, Vol. 48 Issue 4, p632-633. 2p.
Autor:
Stephan Bodis, Brigitte Eberle, Silvia Gomez, Susanne Rogers, Hasler paul, Susanne Desborough, Elisabeth Meier, Lorenz Moser, Istvan Takacs, Debroah Vogt
Publikováno v:
Poster Presentations.
Background: Low dose radiotherapy (LDRT) is an effective treatment for therapy-resistant musculoskeletal disorders that is associated with only minimal toxicities and low costs [1]. As the population in many countries ages and such disorders result i